History
Lidocaine, a foremost amide-type local anesthetic, was developed by Nils Löfgren in 1943 and first marketed inside 1948.

Pharmacology
Lidocaine is metabolized in the liver and excreted by the kidneys. These are sooner acting & yearn lasting than procaine (Novocain).

After given intravenously, xylocaine occurs as class Ib antiarrhythmic agent and will prevent a sodium channel of the cardiac action potential, which decreases automaticity by reducing a slope of phase Four depolarization with little effect on the PR interval, QRS complex or QT interval.

This drug is utilized in the professional assistance of ventricular cardiac arrhythmias and cardiac arrest with ventricular fibrillation, especially with intense ischemia, though it is non utile in the professional assistance of atrial arrhythmias.

A half life of intravenous xylocaine is astir 109 transactions, however because these are metabolized in the liver (which depends in liver blood flow), dosage should become reduced around patients using moo cardiac output or even world health organization come around shock. Within patients by using cardiogenic shock, a half life could exceed 10 hours.

Toxicity
Toxicity is virtually all typically seen after there has been an accidental intravascular injection of xylocaine whilst existence utilized as a local anesthetic. Central nervous system toxicity manifests as dizziness, paresthesia (pins & needles), confusion and – in additional severe events – seizures or coma. Severe toxicity will likewise effect inside cardiovascular system collapse or asystole.

Related Information

Benzocaine Bupivacaine Procaine Cocaine

de:Lidocain fr:Lidocaïne nl:Lidocaïne pl:Lidokaina